Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts.
If you wish to submit a theme issue topic for consideration, please contact one of the editors.
Submission of Manuscripts
Manuscripts should be submitted within the timescales indicated by the Theme Editor. The deadlines that are set must be adhered too
as the publication schedule of the journal is extremely strict. A manuscript is accepted on the understanding that it is not under consideration
for publication elsewhere, that all the named authors have agreed to its submission and that, if accepted, it will not be published again
in the same form, in any language, without the consent of the Publishers.
For the initial submission, the original manuscript plus
three copies, complete with figures (including originals or duplicates of sufficient quality for clarity of reproduction) and tables,
should be submitted to the Theme Issue editor so as to facilitate refereeing. A disk is not required in preliminary stages of refereeing,
but it is absolutely necessary once the final version of the article is accepted for publication. Please include full contact information
- corresponding author name, e-mail address, telephone and fax numbers, and full postal address.
After final acceptance for publication,
your revised manuscript on disk together with two printed hard copies, should be submitted to the Theme Issue editor. It is important
that the file on disk and the printout are identical. See "Electronic manuscripts" below.
Electronic Manuscripts
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing
errors and resulting in reliable and fast delivery of proofs. Files can be stored on 3½ inch diskette. ZIP-disk or CD (either
MS-DOS or Macintosh). Please do not split the manuscript into separate files (title page as one file, text as another, etc.) Ensure
that the letter 'l' and digit '1'(also letter 'O' and digit '0') have been used properly, and format your article (tabs, indents, etc.)
consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but
indicated by a unique code (e.g, gralpha, @, #, etc., for the Greek letter α). Such codes should be used consistently throughout
the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do
not use a 'justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference
style of the journal. It is very important that you save your file in the word processor format. If your word processor features the
option to save files 'in flat ASCII', please do not use it. Format your disk correctly and ensure that only the relevant file
(one complete article only) is on the disk. Also, specify the type of computer and word processing package used, label the disk with
your name and the name of the file on the disk.
Papers should be written in English. There are no page charges. An author checklist can be found
at Elsevier s Quickguide: http://www.elsevier.com.
Papers should conform to the following guidelines:
1. Articles
should be typewritten or printed in (near) letter quality, on one side of the sheet, double-spaced (also references and figure legends),
with a wide margin down the left-hand side of the paper. The Theme Editor should confirm the article length to you as the number of pages
will depend upon the size of the issue. For example a single issue of ADDR should be no greater than 300 pages double spaced and
a double issue should be between 450-500 pages double spaced.
2. The full postal address of the author(s), including
postal code and country, should be given after the authors' names. An indication should be made of one author to whom proofs should be
sent. Please give e-mail address, telephone and fax numbers.
3. An abstract of usually less than 150 words should be supplied.
This summary should state the objective, findings and conclusions of the work reviewed.
4. Key words. A list of 6 to 10
words or short phrases (not already used in the title) should be included on the first page. These terms will be printed after the abstract.
5. General arrangements of papers: (A) reviews should be divided into sections, each headed by a caption (abstract, introduction,
review-specific subtitles, conclusions, references); (B) the sections should be numbered 1, 1.1, 1.1.1 etc. for major sections and subsections,
respectively.
A table of contents specifying the sections and subsections should be supplied.
To enable readers new
to the topic area, we would encourage authors to create well-designed and well-illustrated figures and schemes that give an overview
of the interrelationships among concepts and methodologies.
Tables can also be used to display the breadth and depth of research
in the subject area. There is no predetermined number required.
6. Line-drawn figures should be black ink on white paper
and must be lettered ready for direct reproduction. A high-resolution computer print-out is also acceptable. Alternatively,
sharp photoprints of lettered line-drawings may be submitted. Lettering should not be smaller than 1.5 mm after reduction. Bear in mind
that the page size is 16x20 cm.
7. Half-tone figures should be submitted as sharp, glossy prints, preferably needing no
reduction and with a bar indicating unit length.
8. Legends for both line-drawings and half-tone prints must be typed/printed,
double-spaced, on a separate sheet. The first sentence of the legend should constitute a concise title for the figure.
9. Colour
illustrations should be submitted as original photographs, high-quality computer prints or transparencies, close to the size expected
in publication, or as 35 mm slides. Polaroid colour prints are not suitable. If, together with your accepted article, you submit
usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the web
(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version.
For colour reproduction in print, you will receive information regarding the total cost from Elsevier after receipt of your accepted
article. The 2006 price for color figures is EUR 285 for the first page and EUR 191 for subsequent pages. For more detailed instructions
please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Please note: Because of technical
complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for colour in
print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
10. Nomenclature
and abbreviations. Where possible, nomenclature and abbreviations should be used in accordance with internationally agreed rules.
Only standard abbreviations should be used. Chemical and biochemical abbreviations should be in accordance with the recommendation of
the IUPAC-IUB Combined Commission on Biochemical Nomenclature. Unfamiliar acronyms are not encouraged and no acronyms should appear in
the abstract or title. This information may be found in Biochemical Nomenclature and Related Documents published by the Biochemical
Society (London) for the IUB. Where specialised abbreviations are used in the body of the paper, the name should be given in full in
the first instance with the abbreviation indicated in parentheses.
11. References should be cited in the text by number,
in line with the rest of the text, in square brackets; for example, "according to Smith and Jones [3]". The numbering of the typed list
of references should be in order of citation in the text, not in alphabetical order. References to journals should contain the names
and initials of all the authors, year of publication in parentheses, the title of the paper and the abbreviation of the title of the
journal according to the List of Serial Title World Abbreviations (International Serials Data System, 20 rue Bachaumont, 75002
Paris, France. ISBN 2-904939-02-8). These should be followed by the volume number and first and last page numbers. Reference to a paper
as "in press" implies that it has been accepted for publication. Personal communications and unpublished results should not appear in
the list of references. References to books should include the title of the book, the publishing company and year of publication. For
further details see reference lists in a current issue of the journal.
Examples of journals in the typed list of references:
N.B. The brackets around reference numbers in the reference list itself are generated automatically.
[1] F. Ziang,
Y. Lin, J. Wen, D.W. Matson, R.D. Smith, An integrated microfabricated device for dual microdialysis and on-line ESI-ion trap mass spectrometry
for analysis of complex biological samples, Anal. Chem. 71 (1999) 1485-1490.
[2] H.C. Korting. Preface. The skin as a site for drug
delivery: the liposome approach and its alternatives. Adv. Drug Deliv. Rev. 18 (1996) 271-272.
[3] C. Anderson, C. Svensson, F.
Sjogren, T. Andersson, K. Wardell, Human in vivo microdialysis can be used to measure cytokines in contact reactions, in: P. Elsner,
H.I. Maibach (Eds.), Current Problems in Dermatology, Vol. 23, Karger, Basel, 1995, pp. 121-130.
[4] V. Claassen, Anaesthesia, in:
J.P. Huston (Ed.), Techniques in the Behavioral and Neural Sciences, Neglected Factors in Pharmacology and Neuroscience Research, Vol.
12, Elsevier B.V., Amsterdam, 1994, pp. 25-35.
12. GenBank accession numbers
Gene accession numbers refer to genes
or DNA sequences about which further information can be found in the databases at the National Center for Biotechnical Information (NCBI)
at the National Library of Medicine. Authors wishing to enable other scientists to use the accession numbers cited in their papers via
links to these sources, should reference this information in the following manner:
For each and every accession number cited
in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always
be capitalized. (See Example 1 below). This combination of letters and format will enable Elseiver's typesetters to recognize the relevant
texts as accession numbers and add the required link to GenBank's sequences.
Example 1: '(GenBank accession nos. AI631510,AI631511,AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048),
and a T-cell lymphoma (GeneBank accession no. AA361117)'.
Authors are encouraged to check accession numbers very carefully. An error in a letter or number can result in a dead link..
In the final version of the printedarticle,
the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: 'GenBank accession nos. AI631510,
AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accessionno.BE675048), and a T-cell lymphoma
(GenBank accession no. AA361117)'.
In the final version of the electroniccopy, the accession number text will
be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article (see Example
3 below).
Example 3: 'GeneBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic
leukemia (GenBank accession no. BE67048), and a T-cell lymphoma (GenBank accession no. AA361117)').
13. Acknowledgments.
All acknowledgments, including those for financial support, should be listed in this section. Authors are requested that the source of
all funding that enabled the research to take place be stated.
14. Advanced Drug Delivery Reviews has no page charges.
The 2005 price for color figures is EUR 285.00 for the first page and EUR 191.00 for subsequent pages.
15. Correcting proofs
and reprints. Proofs will be sent to the corresponding author. Elsevier is sending PDF proofs by e-mail for correction. If an author
is unable to handle this process, regular print proofs will be sent. Elsevier will do everything possible to get the article corrected
and published as quickly and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in ONE communication.
Subsequent corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript
will be allowed. Proofs should be returned to Elsevier within 48 hours.
Twenty-five offprints of each paper will be supplied free of
charge to the principal author. Additional offprints can be ordered at prices shown on the order form that accompanies the copyright
form.
16. Copyright guidelines for authors. All authors must sign the "Transfer of Copyright" agreement before the article
can be published. The transfer agreement enables Elsevier to protect the copyrighted material for the authors, but does not relinquish
the author's proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including
reprints, photographic reproductions, microform, or any other reproductions of similar nature and translations, and includes the right
to adapt the article for use in conjunction with computer systems and programs, including reproduction or publication in machine-readable
form and incorporation into retrieval systems. Transfer of copyright agreement forms will be sent to the corresponding author following
acceptance of the manuscript.
If excerpts from other copyrighted works are included, the Author(s) must obtain written permission
from the copyright owners and credit the course(s) in the article. Elsevier has preprinted forms for use by Authors in these cases:
contact Elsevier's Rights Department, Oxford, UK: phone (+44) 1865 843830, fax (+44) 1865 853333, e-mail permissions@elsevier.com.
Requests may also be completed pn-line via the Elsevier homepage (http:www.elsevier.com/locate/permissions)
17. Retained authors' rights. As an author you (or your employer or institution) may do the following: • make
copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use • make
copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues
(but not commercially or systematically, e.g., via an e-mail list or list server) • post a pre-print version of the article
on Internet websites including electronic pre-print servers, and to retain indefinitely such version on such servers or sites •
post a revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on
your personal or institutional website or server, with a link to the journal homepage (on http://www.elsevier.com)
• present the article at a meeting or conference and to distribute copies of the article to the delegates attending such a meeting
• for your employer, if the article is a 'work for hire', made within the scope of your employment, your employer may use all
or part of the information in the article for other intra-company use (e.g., training) • retain patent and trademark rights
and rights to any processes or procedure described in the article • include the article in full or in part in a thesis or dissertation
(provided that this is not to be published commercially) • use the article or any part thereof in a printed compilation of your
works, such as collected writings or lecture notes (subsequent to publication of your article in the journal) • prepare other
derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full
acknowledgement of its original publication in the journal
18. US National Institutes of Health (NIH) voluntary posting ("Public
Access") policy
Elsevier facilitates author posting in connection with the voluntary posting request of the NIH (referred to
as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's
manuscript directly to PubMed Central on request from the author, after formal publication. Upon notification from Elsevier of acceptance,
we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work has received
NIH funding (with the NIH award number, as well as the name and e-mail address of the Prime Investigator) and that you intend to respond
to the NIH request. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will
include peer-review comments, for posting 12 months after the formal publication date. This will ensure that you will have responded
fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting
is prohibited. Individual modifications to this general policy may apply to some Elsevier journals and its society publishing partners.
19. Language services.
Authors who require information about language editing and copyediting services pre- and post-submission,
please visit http://www.elsevier.com/locate/languagepolishing or contact authorsupport@elsevier.com for
more information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside
vendors through our services or in any advertising. For more information please refer to our Terms & Conditions.
20. Author queries. For enquiries relating to the submission of articles (including electronic
submission where available) please visit this journal's homepage at http://www.elsevier.com/locate/addr. You can track
accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's
status has changed. Also accessible from here is information on copyright, frequently asked questions and more.
Contact details
for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Elsevier
Ireland Ltd., Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland
Tel: +353-61-709600; Fax: +353-61-709100; E-mail: authorsupport@elsevier.com.
